“Amgen’s Q4 Earnings: Strong Pipeline and Label Expansions Make It a Must-Buy Stock!”
Amgen Inc.’s Q4 2024 Earnings: A Delicious Surprise A Satisfying Quarter Indeed Amgen Inc. recently served up a delectable treat for investors with its Q4 2024 earnings report. The biotech giant not only beat expectations but did so with flair, showcasing an impressive 11% year-over-year revenue growth and a mouth-watering 13% increase in earnings per…